Liu S - Search Results

1

Prognostic predictive value of preoperative intratumoral 2-deoxy-2-(18F)fluoro-D-glucose uptake heterogeneity in patients with high-grade serous ovarian cancer.

Liu S, Feng Z, Jiang Z, Wen H, Xu J, Pan H, Deng Y, Zhang L, Ju X, Chen X, Wu X. Liu S, et al. Nucl Med Commun. 2018 Oct;39(10):928-935. doi: 10.1097/MNM.0000000000000861. Nucl Med Commun. 2018. PMID: 29771717

2

Tumor-to-background ratios of the maximum standardized uptake value could not indicate the prognosis of advanced high-grade serous ovarian cancer patients.

Liu S, Ju X, Feng Z, Wen H, Xu J, Chen X, Wu X. Liu S, et al. Nucl Med Commun. 2018 Apr;39(4):319-324. doi: 10.1097/MNM.0000000000000798. Nucl Med Commun. 2018. PMID: 29533344

3

¹⁸F-FDG PET/CT can predict chemosensitivity and proliferation of epithelial ovarian cancer via SUVmax value.

Liu S, Feng Z, Wen H, Jiang Z, Pan H, Deng Y, Zhang L, Ju X, Chen X, Wu X. Liu S, et al. Jpn J Radiol. 2018 Sep;36(9):544-550. doi: 10.1007/s11604-018-0755-y. Epub 2018 Jun 25. Jpn J Radiol. 2018. PMID: 29943313

4

Preoperative omental metastasis-related maximum standardized fluorine-18-fluorodeoxyglucose uptake value can predict chemosensitivity and recurrence in advanced high-grade serous ovarian cancer patients.

Sun Y, Liu S, Feng Z, Cheng J, Lu L, Wang M, Yuan H, Xu J, Zhang Y. Sun Y, et al. Among authors: liu s. Nucl Med Commun. 2018 Aug;39(8):761-767. doi: 10.1097/MNM.0000000000000865. Nucl Med Commun. 2018. PMID: 30001265

5

A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study.

Feng Z, Wen H, Jiang Z, Liu S, Ju X, Chen X, Xia L, Xu J, Bi R, Wu X. Feng Z, et al. Among authors: liu s. J Gynecol Oncol. 2018 Sep;29(5):e65. doi: 10.3802/jgo.2018.29.e65. Epub 2018 Apr 23. J Gynecol Oncol. 2018. PMID: 30022629 Free PMC article.

6

18F-FDG PET/CT metabolic parameters and HER2 expression in colorectal cancer.

Yang Z, Liu S, Sun Y, Xu J, Jiang J, Ma X, Zhang Y, Song S. Yang Z, et al. Among authors: liu s. Neoplasma. 2021 Jul;68(4):875-881. doi: 10.4149/neo_2021_200803N807. Epub 2021 May 17. Neoplasma. 2021. PMID: 33998235

7

Radiomics model of 18F-FDG PET/CT imaging for predicting disease-free survival of early-stage uterine cervical squamous cancer.

Liu S, Li R, Liu Q, Sun D, Yang H, Pan H, Wang L, Song S. Liu S, et al. Among authors: liu q. Cancer Biomark. 2022;33(2):249-259. doi: 10.3233/CBM-210201. Cancer Biomark. 2022. PMID: 35213357 Review.

8

¹⁸F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications.

Ye S, Liu S, Xiang L, Wu X, Yang H. Ye S, et al. Among authors: liu s. BMC Cancer. 2019 Mar 13;19(1):226. doi: 10.1186/s12885-019-5441-7. BMC Cancer. 2019. PMID: 30866858 Free PMC article.

9

The role of 18F-FDG PET/CT-based quantitative metabolic parameters in patients with ovarian clear cell carcinoma.

Ye S, Liu S, Zhou S, Xiang L, Wu X, Yang H. Ye S, et al. Among authors: liu s. Cancer Biomark. 2020;27(2):189-194. doi: 10.3233/CBM-190904. Cancer Biomark. 2020. PMID: 31796665 Free PMC article.

10

The feasibility of ¹⁸F-FDG PET/CT for predicting pathologic risk status in early-stage uterine cervical squamous cancer.

Liu S, Xia L, Yang Z, Ge H, Wang C, Pan H, Song S, Zhou Z. Liu S, et al. Cancer Imaging. 2020 Sep 10;20(1):63. doi: 10.1186/s40644-020-00340-z. Cancer Imaging. 2020. PMID: 32912310 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78,309 results

Search Page

Filters